These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 13508497)

  • 1. [Treatment of acute & chronic hepatitis & their sequelae with sulfonylurea].
    PFEFFER KH; ZIMMER V; FUCHS KJ; KLUWE H; MICHEL W
    Arztl Wochensch; 1958 Jan; 13(5):97-105. PubMed ID: 13508497
    [No Abstract]   [Full Text] [Related]  

  • 2. Medical treatment of non-alcoholic steatohepatitis.
    Kadayifci A; Merriman RB; Bass NM
    Clin Liver Dis; 2007 Feb; 11(1):119-40, ix. PubMed ID: 17544975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experience with the treatment of diabetes with sulfonylurea (D 860)].
    BEROVIC R; DEVECERSKI M
    Srp Arh Celok Lek; 1958 Feb; 86(2):157-69. PubMed ID: 13569016
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical research on the treatment of diabetic tuberculotics with sulfonylurea].
    VERGANI F; CAMURATI E; CAZZANI E
    G Ital Della Tuberc; 1957; 11(5):311-6. PubMed ID: 13490810
    [No Abstract]   [Full Text] [Related]  

  • 5. [Value of the insulin-glucose test for qualifying diabetic patients for treatment with sulfonylurea preparations].
    LITYNSKI M
    Pol Tyg Lek (Wars); 1958 Aug; 13(33):1272-6. PubMed ID: 13613994
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of an antidiabetic treatment with sulfonylurea drugs on long-term survival after acute myocardial infarction in patients with type 2 diabetes. The LAngendreer Myocardial infarction and Blood glucose in Diabetic patients Assessment (LAMBDA).
    Meier JJ; Deifuss S; Klamann A; Schmiegel W; Nauck MA;
    Exp Clin Endocrinol Diabetes; 2003 Sep; 111(6):344-50. PubMed ID: 14520601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of acute hepatitis and its transformation into a chronic type].
    Ishibashi D
    Fukuoka Igaku Zasshi; 1989 Aug; 80(8):416-8. PubMed ID: 2583652
    [No Abstract]   [Full Text] [Related]  

  • 8. Sulfonylurea-responsive diabetes in childhood.
    Landau Z; Wainstein J; Hanukoglu A; Tuval M; Lavie J; Glaser B
    J Pediatr; 2007 May; 150(5):553-5. PubMed ID: 17452235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experiences with the sulfonylurea compounds.
    DUNCAN GG; LEE CT; YOUNG JK
    Ann N Y Acad Sci; 1957 Jul; 71(1):233-8. PubMed ID: 13459219
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical use of oral antidiabetics from the sulfonylurea group].
    KNICK B
    Arztl Wochensch; 1958 Jul; 13(28):618-23. PubMed ID: 13571040
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experiences with peroral therapy of diabetes; carbamideurea and sulfonylurea].
    BRKIC D; POPOVIC S; SPASOJEVIC L; MICIC J; BABIC D; RADOSAVLJEVIC M
    Srp Arh Celok Lek; 1959 Jan; 87(1):31-43. PubMed ID: 13659226
    [No Abstract]   [Full Text] [Related]  

  • 12. Do we need new drugs for the treatment of type 2 diabetes mellitus?
    Vervoort G; Tack CJ
    Neth J Med; 2007 May; 65(5):157-9. PubMed ID: 17519510
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experiences with sulfonylurea therapy in tuberculosis of diabetic patients].
    MARTON S; BANYASZ T; MEDVECZKY E
    Orv Hetil; 1958 Jun; 99(26):878-84. PubMed ID: 13566802
    [No Abstract]   [Full Text] [Related]  

  • 14. [Neonatal diabetes mellitus: treatment with sulfonylurea in a preterm born infant].
    Holl RW
    Klin Padiatr; 2009; 221(2):52-3. PubMed ID: 19263321
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effects of sulfonylurea derivatives in diabetes mellitus associated with pulmonary tuberculosis].
    LAURIA D; LIOTTI G; SCOGNAMILLO A
    Riforma Med; 1958 Jun; 72(26):724-7. PubMed ID: 13579942
    [No Abstract]   [Full Text] [Related]  

  • 16. Endoplasmic reticulum stress in beta cells: latent mechanism of secondary sulfonylurea failure in type 2 diabetes?
    Qian L; Zhang S; Xu L; Peng Y
    Med Hypotheses; 2008 Dec; 71(6):889-91. PubMed ID: 18786775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical experience in the treatment of acute and chronic hepatitis as well as of compensated and decompensated liver cirrhosis with the liver hydrolysate prohepar].
    RASBACH K
    Med Monatsschr; 1955 Apr; 9(4):232-6. PubMed ID: 14393497
    [No Abstract]   [Full Text] [Related]  

  • 18. Pioglitazone trial for NASH: results show promise.
    Lang L
    Gastroenterology; 2007 Mar; 132(3):836-8. PubMed ID: 17383411
    [No Abstract]   [Full Text] [Related]  

  • 19. Practical review of oral antihyperglycemic agents for type 2 diabetes mellitus.
    Koski RR
    Diabetes Educ; 2006; 32(6):869-76. PubMed ID: 17102154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulfonylurea and glinide reduce insulin content, functional expression of K(ATP) channels, and accelerate apoptotic beta-cell death in the chronic phase.
    Takahashi A; Nagashima K; Hamasaki A; Kuwamura N; Kawasaki Y; Ikeda H; Yamada Y; Inagaki N; Seino Y
    Diabetes Res Clin Pract; 2007 Sep; 77(3):343-50. PubMed ID: 17316868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.